Differential (Click to cross reference) adverse drug reaction anticoagulant, treatment anticoagulant, treatment in CVD aspirin atrial fibrillation atrial fibrillation, risk stratification cerebrovascular accident cerebrovascular accident, prevention of CHADS-VaSC score complications controversies in neurology coumarin dabigatran dabigatran, dose efficacy HAS-BLED score head injury INR value, time in range INR values intracerebral hemorrhage practice guidelines prevention of neurologic disorders prognosis RELY trial risk factors risk factors, modification safety subdural hematoma thrombin inhibitor trauma treatment of neurologic disorder

Showing articles 200 to 208 of 208 << Previous Apolipoprotein E Genotyping in Alzheimer's Disease Lancet 347:1091-1095, Tanzi,R.,et al, 1996 Research Involv Subj with Dementia & Other Cognitive Impairments:NIH, & Ethical Considerations Neurol 45:1777-1778, Wichman,A.&Sandler,A.L., 1995 Inclusion Body Myositis and Myopathies Ann Neurol 38:705-713, Griggs,R.C.,et al, 1995 Betaseron for Multiple Sclerosis:Implications for Therapeutics Arch Neurol 51:125-128, Rudick,R., 1994 Evolving Toward Effective Therapy for Acute Ischemic Stroke JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993 The Results of Clinical Trials in Stroke Rehabilitation Research Arch Neurol 50:37-44, ottenbacher,K.J.&Jannell,S., 1993 Vascular Dementia:Diagnostic Criteria for Research Studies, Report of the NINDS-AIREN Intern'l Workshop Neurol 43:250-260, Romas,G.C.,et al, 1993 Use of Twin Cohorts for Research in Alzheimer's Disease Neurol 43:261-267, Breitner,J.C.S.,et al, 1993 The Use of Fetal Tissue in Research on Parkinson's Disease NEJM 327:1591-1592, Kassirer,J.P.&Angell,M., 1992 Showing articles 200 to 208 of 208 << Previous